找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Novel Inhibitors of Leukotrienes; Giancarlo Folco,Bengt Samuelsson,Robert C. Murphy Book 1999 Springer Basel AG 1999 asthma.cell.developme

[復制鏈接]
查看: 20726|回復: 60
樓主
發(fā)表于 2025-3-21 16:25:42 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Novel Inhibitors of Leukotrienes
編輯Giancarlo Folco,Bengt Samuelsson,Robert C. Murphy
視頻videohttp://file.papertrans.cn/669/668406/668406.mp4
叢書名稱Progress in Inflammation Research
圖書封面Titlebook: Novel Inhibitors of Leukotrienes;  Giancarlo Folco,Bengt Samuelsson,Robert C. Murphy Book 1999 Springer Basel AG 1999 asthma.cell.developme
描述Many new antileukotriene drugs are now marketed as antiasthma drugs and represent the first new drugs in this field since the 1970s. This book covers the steps that have led to the discovery and development of these new drugs and offers detailed descriptions of their clinical applications. The review chapters on the main aspects of basic and applied leukotriene research are written by leading specialists in the field, and the volume takes a new approach in presenting information of particular interest to both scientists and clinicians in the fields of asthma, inflammation and allergic diseases.
出版日期Book 1999
關鍵詞asthma; cell; development; diseases; drugs; inflammation; metabolism; pharmaceutical; research
版次1
doihttps://doi.org/10.1007/978-3-0348-8703-8
isbn_softcover978-3-0348-9736-5
isbn_ebook978-3-0348-8703-8Series ISSN 1422-7746 Series E-ISSN 2296-4525
issn_series 1422-7746
copyrightSpringer Basel AG 1999
The information of publication is updating

書目名稱Novel Inhibitors of Leukotrienes影響因子(影響力)




書目名稱Novel Inhibitors of Leukotrienes影響因子(影響力)學科排名




書目名稱Novel Inhibitors of Leukotrienes網絡公開度




書目名稱Novel Inhibitors of Leukotrienes網絡公開度學科排名




書目名稱Novel Inhibitors of Leukotrienes被引頻次




書目名稱Novel Inhibitors of Leukotrienes被引頻次學科排名




書目名稱Novel Inhibitors of Leukotrienes年度引用




書目名稱Novel Inhibitors of Leukotrienes年度引用學科排名




書目名稱Novel Inhibitors of Leukotrienes讀者反饋




書目名稱Novel Inhibitors of Leukotrienes讀者反饋學科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-21 21:06:08 | 只看該作者
,The development of zafirlukast (Accolate?) and the Zeneca series of peptidyl-leukotriene receptor a LrE.. Together they account for the biological activity of slow-reacting substance of anaphylaxis (SRS-A), which was discovered nearly 40 years ago when it was distinguished from histamine by its ability to produce a slowly developing and long-lasting contraction of isolated guinea pig ileum [2].
板凳
發(fā)表于 2025-3-22 01:47:18 | 只看該作者
地板
發(fā)表于 2025-3-22 07:47:00 | 只看該作者
1422-7746 es a new approach in presenting information of particular interest to both scientists and clinicians in the fields of asthma, inflammation and allergic diseases.978-3-0348-9736-5978-3-0348-8703-8Series ISSN 1422-7746 Series E-ISSN 2296-4525
5#
發(fā)表于 2025-3-22 11:15:25 | 只看該作者
6#
發(fā)表于 2025-3-22 14:00:16 | 只看該作者
Metabolism of leukotrienes and formation of new leukotriene structures,pathways involved in metabolic processing are common to a host of other endogenous biochemical substances, in particular eicosanoids such as prostaglandins and thromboxanes. However, there are several enzymes rather specific for certain leukotrienes, suggesting a more unique role for such metabolic events mediated by these enzymes.
7#
發(fā)表于 2025-3-22 18:12:38 | 只看該作者
8#
發(fā)表于 2025-3-23 01:08:14 | 只看該作者
9#
發(fā)表于 2025-3-23 03:01:37 | 只看該作者
The development of iralukast: A member of the Novartis series of cysteinyl leukotriene antagonists,lukast (AccolateTM, ICI 204,219) and montelukast (SingulairTM, MK 0476) are available on the market as treatment for asthma [1–6]. Further compounds, such as iralukast (CGP 45715A) are in development for this indication [7,8].
10#
發(fā)表于 2025-3-23 06:50:15 | 只看該作者
Book 1999w chapters on the main aspects of basic and applied leukotriene research are written by leading specialists in the field, and the volume takes a new approach in presenting information of particular interest to both scientists and clinicians in the fields of asthma, inflammation and allergic diseases.
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-26 02:25
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
扬州市| 公安县| 漾濞| 英超| 济阳县| 芜湖县| 广汉市| 平原县| 九龙坡区| 奇台县| 河北省| 保德县| 友谊县| 文安县| 伊吾县| 襄汾县| 奎屯市| 华安县| 佛教| 香格里拉县| 贺兰县| 宁陕县| 札达县| 木里| 德昌县| 青河县| 崇阳县| 原平市| 安丘市| 清涧县| 上杭县| 咸丰县| 镇安县| 吴堡县| 灵台县| 临洮县| 赤壁市| 远安县| 永泰县| 迁西县| 静海县|